Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
1 clinical trials · Condition
◉ Watch Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer (NCT04061980) | Providence Health & Services | 2020-10-30 |
Track Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.